RT Journal
A1 Tachibana M, Kinugasa S, Dhar D, et al
T1 PRognostic factors in t1 and t2 squamous cell carcinoma of the thoracic esophagus
JF Archives of Surgery
JO Archives of Surgery
YR 1999
FD January 1
VO 134
IS 1
SP 50
OP 54
DO 10.1001/archsurg.134.1.50
UL http://dx.doi.org/10.1001/archsurg.134.1.50
AB Background 
    Prognostic indicators in patients with T2 tumor have not been fully understood.Objective 
    To clarify the clinicopathologic characteristics and long-term results of T1 and T2 squamous cell carcinomas of the thoracic esophagus.Design 
    Consecutive case series.Setting 
    Department of surgery in a university hospital.Patients 
    Of 234 patients with primary squamous cell carcinoma of the thoracic esophagus, 142 patients underwent esophagectomy with curative intent: 97 patients had pT1 and pT2 tumors.Interventions 
    Investigated were clinicopathologic characteristics of 65 of 97 patients with pT1 and pT2 tumors; excluded were 7 patients who died of postoperative complications and another 25 patients who died of causes other than esophageal cancer.Main Outcome Measures 
    Clinicopathologic characteristics and long-term results.Results 
    Pathologic tumor stages were pT1 N0 in 23 patients, pT1 N(+) in 7 patients, pT2 N0 in 15 patients, and pT2 N(+) in 20 patients. Fifty patients are alive and free of cancer and 15 patients died of tumor recurrence (1 patient with pT1 N0 tumor, 1 patient with pT1 N[+][+] tumor, 1 patient with pT2 N0 tumor, and 12 patients with pT2 N[+] tumor). The sites of metastatic nodes in 6 survivors with pT1 N(+) tumor were a solitary perigastric node in 4 patients, a solitary mediastinal node in 1 patient, and 2 mediastinal nodes in 1 patient. The 5-year survival rates of patients with pT1 N0, pT1 N(+), and pT2 N0 tumors all exceeded 85%, and the rate of those with pT2 N(+) tumor was 33.9% (pT2 N[+] vs others: pT1 N0, pT1 N[+], and pT2 N0; P=.003). The factors affecting survival rate by univariate analysis were Borrmann classification (0, 1 vs 2, 3, 4), tumor size (<4.0 vs ≥4.0 cm), combined T, N factor (pT2 N[+] vs others), time of operation (≤420 vs >420 minutes), estimated blood loss (<1000 vs ≥1000 mL), and lymph vessel invasion (marked vs not marked). Stage pT2 N(+) tumor became a single independent prognostic factor for survival as determined by multivariate analysis (pT2 N[+] vs others; P=.008).Conclusions 
    Stage pT1 N(+) tumors with a few diseased nodes and pT2 N0 tumors are considered to be a group with an excellent prognosis, similar to pT1 N0 tumors. Patients with pT2 N(+) diseases had worse prognoses and thus should have meticulous lymph node dissection and extensive adjuvant therapy.